stockrowDoximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) EBITDA
Doximity, Inc.'s EBITDA for fiscal 2026 was $235.2M, unchanged from fiscal 2025. Over the twelve months to 30 June 2026 it was $218.1M. Over the past ten years it has ranged from $12.5M (fiscal 2019) to $236.8M (fiscal 2025); the current reading is higher than 88% of that period. Doximity, Inc. ranks 6th of 43 Health Information Services companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | $235.2M | (0.66%) |
| FY2025 | $236.8M | 33.19% |
| FY2024 | $177.8M | 20.70% |
| FY2023 | $147.3M | 11.03% |
| FY2022 | $132.7M | 107.01% |
| FY2021 | $64.1M | 131.42% |
| FY2020 | $27.7M | 122.27% |
| FY2019 | $12.5M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $41.7M | 30.06% |
| Mar 2026 | $32.0M | (58.19%) |
| Dec 2025 | $76.6M | 12.96% |
| Sep 2025 | $67.8M | 15.51% |
| 22 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $690.0M |
| HQY HealthEquity, Inc. compare | $510.0M |
| WAY Waystar Holding Corp. compare | $444.3M |
| DOCS Doximity, Inc. | $218.1M |
| HNGE Hinge Health Inc. compare | $161.2M |
| PRVA Privia Health Group, Inc. compare | $63.8M |
| HTFL Heartflow, Inc. compare | −$72.7M |
| SDGR Schrodinger, Inc. compare | −$127.8M |
| TEM Tempus AI, Inc. compare | −$166.8M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement